Status:
COMPLETED
A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis
Lead Sponsor:
Allergan
Conditions:
Hyperhidrosis
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
This is a three-year study in subjects with axillary hyperhidrosis involving injection of Botulinum Toxin Type A into the axilla to reduce sweating.
Eligibility Criteria
Inclusion
- Marked axillary hyperhidrosis
Exclusion
- Previous use of botulinum toxin for hyperhidrosis
Key Trial Info
Start Date :
February 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2005
Estimated Enrollment :
193 Patients enrolled
Trial Details
Trial ID
NCT00168402
Start Date
February 1 2002
End Date
October 1 2005
Last Update
May 30 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.